Embecta (EMBC) Change in Accured Expenses (2020 - 2026)
Embecta (EMBC) reported Change in Accured Expenses of $8.8 million for Q1 2026, up 144.67% on a YoY basis from $3.6 million in Q1 2025, and up 136.97% sequentially from -$23.8 million in Q4 2025.
Embecta (EMBC) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Embecta (EMBC) has 7 years of Change in Accured Expenses data on file, last reported at $8.8 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 144.67% year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at -$23.4 million (down 2500.0% YoY), and the FY2025 full-year result was -$68.9 million, down 214.83% from the prior year.
- Change in Accured Expenses rose to $8.8 million in Q1 2026, from -$23.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $88.4 million in Q2 2022 to a low of -$45.4 million in Q3 2023.
- A 5-year average of $3.7 million and a median of $3.3 million in 2025 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses plunged 1294.74% in 2023 and surged 5266.67% in 2024, its largest moves.
- Tracing EMBC's Change in Accured Expenses over 5 years: stood at $19.4 million in 2022, then sank by 180.93% to -$15.7 million in 2023, then plunged by 159.87% to -$40.8 million in 2024, then surged by 41.67% to -$23.8 million in 2025, then jumped by 136.97% to $8.8 million in 2026.
- Business Quant data shows EMBC's Change in Accured Expenses at $8.8 million in Q1 2026, -$23.8 million in Q4 2025, and -$11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -260.40 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -151.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 5.38 Mn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | 8.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.80 Mn |
| Mar 31, 2026 | 8.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Sep 30, 2025 | -11.70 Mn |
| Sep 30, 2025 | -11.70 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Dec 31, 2024 | -40.80 Mn |
| Dec 31, 2024 | -40.80 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Dec 31, 2023 | -15.70 Mn |
| Dec 31, 2023 | -15.70 Mn |